Laura Romer, APRN
Psychiatric/Mental Health, Adult · Saint Louis, MONPI 1477697746
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $187 and has fallen 61.6% since, to $72 in 2025.
Across 26 payments — averaging $22.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$127
- Otsuka America Pharmaceutical, Inc.$125
- Alkermes, Inc.$112
- Johnson & Johnson$54
- Indivior Inc.$52
- Luye Pharma (USA) Ltd.$30
- plus $72 from 3 others
What the payments were for
- Food & beverage$572100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $127 |
| Otsuka America Pharmaceutical, Inc. | 6 | $125 |
| Alkermes, Inc. | 5 | $112 |
| Johnson & Johnson | 3 | $54 |
| Indivior Inc. | 1 | $52 |
| Luye Pharma (USA) Ltd. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
How this compares
Too few psychiatric/mental health, adult providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 113 | $331,725 |
| Invega TrinzaPaliperidone Palmitate | 25 | $210,746 |
| VraylarCariprazine Hcl | 82 | $96,436 |
| Abilify MaintenaAripiprazole | 30 | $88,167 |
| UzedyRisperidone | 18 | $69,382 |
| AustedoDeutetrabenazine | 16 | $46,692 |
| AristadaAripiprazole Lauroxil | 13 | $40,906 |
| Clozapine | 500 | $20,164 |
| Paliperidone ErPaliperidone | 91 | $18,114 |
| Divalproex Sodium ErDivalproex Sodium | 196 | $12,448 |
| Varenicline Tartrate | 33 | $10,094 |
| Olanzapine | 242 | $6,484 |
| TrintellixVortioxetine Hydrobromide | 12 | $6,094 |
| Duloxetine Hcl | 202 | $4,944 |
| Haloperidol | 198 | $4,895 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna, Invega Trinza | $54 | $542,470138 claims |
| Teva Pharmaceuticals USA, Inc.Uzedy, Austedo | $19 | $116,07334 claims |
| AbbVieVraylar | $127 | $96,43682 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $125 | $88,16730 claims |
| Alkermes, Inc.Aristada | $112 | $40,90613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few psychiatric/mental health, adult providers in Missourion file to place this against a meaningful peer group, so we don't.
Other psychiatric/mental health, adult in Saint Louis
- Jeffrey BoatmanSaint Louis$7K
- Theresa KormosSaint Louis$2K
- Sherry DoneySaint Louis$293
- Shari HelbigSaint Louis$86
- Donna GrahamSaint Louis$70
- Ivy AlwellHillsboro$6K
- Veneta RaboinMexico$3K
- Carolyn GreeningHannibal$475
- Janet MurdickFestus$268
- Jeana WilcoxKansas City$194
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.